CODX vs PODD
Co-Diagnostics, Inc. Common Stock (CODX) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CODX currently screens at market cap $31.4M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CODX and PODD stock pages for the full models.
Not investment advice.